Conferences

The LJWG runs regular meetings and conferences to keep stakeholders updated on progress, to share new evidence and to provide a forum for expert discussion on how to improve service provision and improve outcomes in hepatitis C for people who use drugs.

Click on the event details below to see presentations from past meetings and conferences.

2014 CONFERENCE: HEPATITIS C IN LONDON: PRACTICAL STEPS TO ELIMINATION
The conference explored the issues around elimination of hepatitis C in people who use drugs in London – and asked: Is it feasible? How could it be achieved? How could we make services easier for people to access?
The agenda included details of the updated LJWG London Consensus, the latest health outcome models and best practice from around the UK.

[divider]
[space height=”20″]

2014 SYMPOSIUM AT EASL: ELIMINATING HEPATITIS C WITH A GENERATION: WHAT ARE YOU GOING TO DO ABOUT IT? CONSENSUS
A LJWG symposium held at the International Liver Congress in London united stakeholders involved in the care and treatment of hepatitis C to demand that urgent action is taken to help eliminate the hepatitis C virus by 2030.
98% of the meeting attendees agreed that there is an opportunity to eliminate hepatitis C by 2030, and that every effort should be made to do so.

[divider]
[space height=”20″]

2013 CONFERENCE: HOW TO MAKE A DIFFERENCE: PRACTICAL STEPS TO IMPLEMENTING THE LONDON CONSENSUS
The conference presented results from London boroughs piloting the London Consensus recommendations, and debated the implications for commissioners of the Public Health Report on Commissioning Hepatitis C Services in London for People who Inject Drugs.

[divider]
[space height=”20″]

2011 CONFERENCE: SUBSTANCE MISUSE, HEPATITIS C AND HEALTH INEQUALITIES IN LONDON: INSPIRING ACTION FOR THE FUTURE 

The second LJWG conference focused on practical advice and support for the implementation of the consensus recommendations.

Held in London in November 2011, the programme included presentations from Anne Milton, Under-Secretary of State for Public Health; Dr Simon Tanner, Director of Public Health for NHS London; Paul Hayes, CEO, National Treatment Agency for Substance Misuse; and Dr Nigel Hewitt, Medical Director, London Pathway; as well as case studies and experience from projects and programmes across the UK.

[divider]
[space height=”20″]

2010 CONFERENCE: HEPATITIS C, SUBSTANCE MISUSE AND HEALTH INEQUALITIES: DELIVERING A CONSENSUS FOR LONDON

The first LJWG conference was held in October 2010. The purpose was to highlight the lack of support for people who use drugs to get treatment for hepatitis C, and to develop a stakeholder consensus on what needs to be done to integrate health and addiction services in London to tackle health inequalities and stop the spread of the virus.